Patents by Inventor Benjamin Luft

Benjamin Luft has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Groups Of Borrelia Burgdorferi And Borrelia Afzelii That Cause Lyme Disease In Humans
    Publication number: 20090060932
    Abstract: The present invention is drawn to an immunogenic composition comprising OspC polypeptides from Lyme Disease causing Borrelia. In one embodiment, the immunogenic composition of the present invention comprises at least one OspC polypeptide or immunogenic fragment thereof from each of Borrelia burgdorferi OspC families A, B, I and K. In another embodiment, the immunogenic composition of the present invention comprises at least one OspC polypeptide or immunogenic fragment thereof from each of Borrelia afzelii OspC families A and B.
    Type: Application
    Filed: March 9, 2006
    Publication date: March 5, 2009
    Applicants: Research Foundation of the State University of New York, Brook Biotechnologies, Inc.
    Inventors: Raymond Dattwyler, Gerald Seinost, Daniel Dykhuizen, Benjamin Luft, Maria Gomes-Solecki
  • Recombinant constructs of Borrelia burgdorferi
    Publication number: 20070020286
    Abstract: Novel chimeric nucleic acids, encoding chimeric Borrelia proteins comprising OspC or an antigenic fragment thereof and OspA or an antigenic fragment thereof, are disclosed. Chimeric proteins encoded by the nucleic acid sequences are also disclosed. The chimeric proteins are useful as vaccine immunogens against Lyme borreliosis, as well as for immunodiagnostic reagents.
    Type: Application
    Filed: September 26, 2006
    Publication date: January 25, 2007
    Inventors: Raymond Dattwyler, Maria Gomes-Solecki, Benjamin Luft, John Dunn
  • Groups of Borrelia burgdorferi and Borrelia afzelii that cause Lyme Disease in humans
    Publication number: 20060182756
    Abstract: The present invention is drawn to an immunogenic composition comprising OspC polypeptides from Lyme Disease causing Borrelia. In one embodiment, the immunogenic composition of the present invention comprises at least one OspC polypeptide or immunogenic fragment thereof from each of Borrelia burgdorferi OspC families A, B, I and K. In another embodiment, the immunogenic composition of the present invention comprises at least one OspC polypeptide or immunogenic fragment thereof from each of Borrelia afzelii OspC families A and B.
    Type: Application
    Filed: March 9, 2006
    Publication date: August 17, 2006
    Inventors: Raymond Dattwyler, Gerald Seinost, Daniel Dykhuizen, Benjamin Luft, Maria Gomes-Solecki
  • Recombinant constructs of Borrelia burgdorferi
    Publication number: 20050271682
    Abstract: Novel chimeric nucleic acids, encoding chimeric Borrelia proteins comprising OspC or an antigenic fragment thereof and OspA or an antigenic fragment thereof, are disclosed. Chimeric proteins encoded by the nucleic acid sequences are also disclosed. The chimeric proteins are useful as vaccine immunogens against Lyme borreliosis, as well as for immunodiagnostic reagents.
    Type: Application
    Filed: August 3, 2005
    Publication date: December 8, 2005
    Inventors: Raymond Dattwyler, Maria Gomes-Solecki, Benjamin Luft, John Dunn